These findings offer a novel framework for understanding treatment-resistant hypertension in malaria-endemic regions and identify the <i>Rac1</i> promoter as a candidate nexus for developing dual-disease therapeutic strategies tailored to high-burden populations. The gene discussed is RAC1; the disease is hypertensive disorder.